PACIRA BIOSCIENCES INC. - COMMON STOCK

LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions

23 Feb 2023 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million

05 Jan 2023 15:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022

13 Dec 2022 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022

14 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at Two Healthcare Conferences in November

08 Nov 2022 07:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2022 Financial Results

03 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022

20 Oct 2022 07:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million

13 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expanded Access to EXPAREL for Patients Undergoing Oral and Maxillofacial Procedures

27 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy

21 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

Pacira Receives Positive CHMP Opinion for EXPAREL® for the Treatment of Postsurgical Pain in Children Aged 6 or Older

20 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022

13 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty

07 Sep 2022 06:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022

10 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain

09 Aug 2022 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Second Quarter 2022 Financial Results

03 Aug 2022 07:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference

02 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022

27 Jul 2022 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million

14 Jul 2022 06:30:00 By Nasdaq GlobeNewswire